---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-002818"
form_type: "8-K"
ticker: "MTNB"
cik: "0001582554"
company_name: "Matinas BioPharma Holdings, Inc."
filed_at: "2025-04-04T23:59:59+00:00"
generated_at: "2026-05-23T21:01:53.700133+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Matinas BioPharma shareholders approve issuance of up to 16.9M shares and ratify auditor

## Summary
- Proposal 1 passed with 88% of votes cast; authorizes up to 16,894,212 common shares upon conversion of Series C Preferred and warrants.
- Proposal 2 ratified EisnerAmper LLP as independent auditor for FY2025 with 95% of votes cast.
- Proposal 3 to adjourn meeting if needed approved with 90% of votes cast.
- Shareholders representing 52.47% of outstanding shares were present at the Special Meeting on April 4, 2025.

## SEC filing metadata
- accession: 0001641172-25-002818
- form_type: 8-K
- ticker: MTNB
- cik: 0001582554
- company_name: Matinas BioPharma Holdings, Inc.
- filed_at: 2025-04-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582554/000164117225002818/0001641172-25-002818-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582554/000164117225002818/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-002818
- JSON: https://secwatch.observer/filing/0001641172-25-002818.json
- Plain text: https://secwatch.observer/filing/0001641172-25-002818.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.